An Investigation into the Factors Influencing Drug Release from Hydrophilic Matrix Tablets Based on Novel Carbomer Polymers

Drug Delivery: Journal of Delivery and Targeting of Therapeutic Agents

Volumn 11, Issue 1, 2004, Pages 59-65

  Parojčić, Jelena ^a,b   Durić, Zorica ^a   Jovanović, Milica ^a   Ibrić, Svetlana ^a  

^a Faculty of Pharmacy   (Serbia)

^b Faculty of Pharmacy   (Serbia)

Author keywords

Carbomer; Dissolution; Drug Delivery; Hydrophilic Matrix Tablet; Paracetamol; Sustained Release

Indexed keywords

CARBOMER; LACTOSE; MICROCRYSTALLINE CELLULOSE; PARACETAMOL; POVIDONE; SILICON DIOXIDE;

ARTICLE; DRUG RELEASE; GEOMETRY; HYDRATION; HYDROPHILICITY; MATHEMATICAL MODEL; MATRIX TABLET; MULTIPLE REGRESSION; PRIORITY JOURNAL; SURFACE PROPERTY;

EID: 19244378905     PISSN: 10717544     EISSN: None     Source Type: Journal    
DOI: 10.1080/10717540490265379     Document Type: Article

References (16)

1. Amidon, L. G., and Lobenberg, R. 2000. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 50:3-12.
2. Box, G. E. P., Hunter, W. G., and Hunter, J. S. 1978. Statistic for Experimenters. An Introduction to Design, Data Analysis and Model Building, New York: John Wiley & Sons.
3. Channer, K. S., and Virjee, J. P. 1986. The effect of size and shape of tablets on their esophageal transit. J. Clin. Pharmacol. 26:141-146.
4. Fereira, D. C., Prista, L. V., Morgado, R. M., and Lobo, J. M. S. 1995. Sustained-release tablet containing oxazepam: Study and design. Drug Dev. Ind. Pharm. 21:591-604.
5. Huang, L. L., and Schwartz, B. J. 1995. Studies on drug release from a carbomer tablet matrix. Drug Dev. Ind. Pharm. 21:1487-1501.
6. Karasulu, H. Y., Ertan, G., and Kose, T. 2000. Modeling of theophylline release from different geometrical erodible tablets. Eur. J. Pharm. Biopharm. 49:177-182.
7. Khan, G. M., and Zhu, J. B. 1999. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: Influence of co-excipients on release rate of the drug. J. Control. Rel. 57:197-203.
8. Kim, C. J. 1995. Compressed donut-shaped tablets with zero-order release kinetics. Pharm. Res. 12:1045-1048.
9. Montgomery, D. 1997. Design and Analysis of Experiments, 4th Ed. New York: John Wiley & Sons.
10. Perez-Marcos, B., del Cano, O., Gomez-Amoza, J. L., Martinez-Pacheco, R., Souto, C., and Concheiro, A. 1995. Design and biopharmaceutical evaluation of atenolol matrix tablets prepared with carbomer 934. STP Pharma 5:105-109.
11. Ritger, P., and Peppas, N. 1987. A simple equation for description of solute release II: Fickian and anomalous release from swellable devices. J. Control. Rel. 5:37-42.
12. Siepmann, J., Ainaoui, A., Vergnaud, J. M., and Bodmeier, R. 1998. Calculation of the dimensions of drug-polymer devices based on diffusion parameters. J. Pharm. Sci. 87:827-832.
13. Siepmann, J., Kranz, H., Peppas, N. A., and Bodmeier, R. 2000. Calculation of the required size and shape of hydroxypropylmethylcellulose matrices to achieve desired drug release profiles. Int. J. Pharm. 201:151-164.
14. Siepmann, J., Streubel, A., and Peppas, N. A. 2002. Understanding and predicting drug delivery from hydrophilic matrix tablets using the "sequential layer" model. Pharm. Res. 19:306-314.
15. Reynolds, T. D., Mitchell, S. A., and Balwinski, K. M. 2002. Investigation of the effect of tablet surface area/volume on drug release from hydroxypropylmethylcellulose controlled-release matrix tablets. Drug Dev. Ind. Pharm. 28:457-466.
16. Wilson, G. C. 1998. Gastrointestinal transit and drug absorption. In Biopharmaceutics Classification System and In Vitro-In Vivo Correlations, APV Kurs. Frankfurt, Germany, 23-25 March 1998.